Search research articles
Contact Us
Filters
Showing results (11-20 of 105) with videos related to
Page
of 11
Sort By:
European Journal of Pharmacology
|
March 1, 1979
High-affinity 3H-imipramine binding in rat cerebral cortex
R Raisman, M Briley, S Z Langer
European Journal of Pharmacology
|
February 1, 1980
Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding
R Raisman, M S Briley, S Z Langer
European Journal of Pharmacology
|
May 30, 1980
Stereoselective inhibition of 3H-imipramine binding by antidepressant drugs and their derivatives
S Z Langer, R Raisman, M S Briley
Drug Safety
|
December 20, 1999
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?
M G Murer, R Raisman-Vozari, O Gershanik
European Journal of Pharmacology
|
October 1, 1979
Human platelets possess high-affinity binding sites for 3H-imipramine
M S Briley, R Raisman, S Z Langer
Journal De Pharmacologie
|
October 1, 1986
The pharmacological effects of acute and chronic clenbuterol treatments after lesions of central noradrenergic nerve terminals
H Francès, I Struck, P Simon, et al.
Journal of Neurochemistry
|
October 1, 1987
Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease
R Cash, R Raisman, A Ploska, et al.
European Journal of Pharmacology
|
October 29, 1985
High and low affinity [3H]imipramine binding sites in control and parkinsonian brains
R Cash, R Raisman, A Ploska, et al.
Progress in Neurobiology
|
October 21, 2000
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease
M G Murer, Q Yan, R Raisman-Vozari
Biochemical Pharmacology
|
February 15, 1978
Role of cyclic AMP and angiotensin III in the response of toad skin to angiotensin II
A Coviello, R Raisman, G Elso, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 105) with videos related to
Sort By:
Page
of 11
European Journal of Pharmacology
|
March 1, 1979
High-affinity 3H-imipramine binding in rat cerebral cortex
R Raisman, M Briley, S Z Langer
European Journal of Pharmacology
|
February 1, 1980
Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding
R Raisman, M S Briley, S Z Langer
European Journal of Pharmacology
|
May 30, 1980
Stereoselective inhibition of 3H-imipramine binding by antidepressant drugs and their derivatives
S Z Langer, R Raisman, M S Briley
Drug Safety
|
December 20, 1999
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?
M G Murer, R Raisman-Vozari, O Gershanik
European Journal of Pharmacology
|
October 1, 1979
Human platelets possess high-affinity binding sites for 3H-imipramine
M S Briley, R Raisman, S Z Langer
Journal De Pharmacologie
|
October 1, 1986
The pharmacological effects of acute and chronic clenbuterol treatments after lesions of central noradrenergic nerve terminals
H Francès, I Struck, P Simon, et al.
Journal of Neurochemistry
|
October 1, 1987
Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease
R Cash, R Raisman, A Ploska, et al.
European Journal of Pharmacology
|
October 29, 1985
High and low affinity [3H]imipramine binding sites in control and parkinsonian brains
R Cash, R Raisman, A Ploska, et al.
Progress in Neurobiology
|
October 21, 2000
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease
M G Murer, Q Yan, R Raisman-Vozari
Biochemical Pharmacology
|
February 15, 1978
Role of cyclic AMP and angiotensin III in the response of toad skin to angiotensin II
A Coviello, R Raisman, G Elso, et al.
Page
of 11